Issues for Referral
- Primary care physician to coordinate care
- Cardiologist for diagnosis, medical management, and ongoing monitoring
- Cardiothoracic evaluation for surgery
FOLLOW-UP RECOMMENDATIONS
- Plan for follow-up should be determined in consult with the pediatric cardiologist.
- Clear instructions for return visits, as any physiologic stress may worsen condition.
PEARLS AND PITFALLS
- Visual appearance of cyanosis requires >3–5 mg/dL deoxygenated hemoglobin.
- Duct-dependent lesions:
- Present at 2–3 wk of age
- Sudden cyanosis or cardiovascular collapse
- Treat with PGE1:
- Beware apnea and hypotension
ADDITIONAL READING
- Apitz C, Webb GD, Redington AN. Tetralogy of Fallot.
Lancet
. 2009;374:1462–1471.
- Bonow RO, Mann DL, Zipes DP, et al., eds. Congenital heart disease.
Braunwald’s Heart Disease
. 98th ed. Philadelphia, PA: Saunders Elsevier; 2012:1411–1467.
- Dolbec K, Mick N. Congenital heart disease.
Emerg Med Clin North Am.
2011;29:811–827.
- Fleisher GR, Ludwig S, Bachur RG, et al., eds. Cardiac emergencies.
Textbook of Pediatric Emergency Medicine
. 6th ed. Philadelphia, PA: Lippincott Williams, & Wilkins, 2010:690–701.
- Yee L. Cardiac emergencies in the first year of life.
Emerg Med Clin North Am
. 2007;25:981–1008.
CODES
ICD9
- 745.2 Tetralogy of fallot
- 745.4 Ventricular septal defect
- 746.89 Other specified congenital anomalies of heart
ICD10
- Q21.0 Ventricular septal defect
- Q21.3 Tetralogy of Fallot
- Q24.8 Other specified congenital malformations of heart
CONGESTIVE HEART FAILURE
Naomi George
•
Robert A. Partridge
BASICS
DESCRIPTION
- A clinical syndrome in which the heart fails to maintain adequate circulation for metabolic needs, characterized by chronic debility, acute decompensation, and high mortality.
- Acute Decompensated Heart Failure (ADHF) is a rapidly progressive failure state (hr–days)
- Common reason for presentation to the ED
- Usually caused by a precipitating event in which the heart does not have the reserve to compensate for the added burden
- Chronic HF is a progressive failure state (mo–yr) characterized by cardiac remodeling and neurohormonal changes, with multiple subclasses:
- Systolic heart failure
- Impaired contractile or pump function causing decreased ejection fraction
- Diastolic heart failure
- Impaired ventricular relaxation resulting in decreased cardiac filling
- Low-output failure
- High-output failure:
- Normal or increased cardiac output, but insufficient to meet metabolic demands
- Left-sided failure
- Systolic or diastolic (or both) dysfunction of the left ventricle
- Resultant pulmonary congestion
- Right-sided heart failure
- Due to either intrinsic dysfunction or secondary to left heart failure or pulmonary hypertension (cor pulmonale)
- Hepatic enlargement, JVD, and dependent edema can occur
- CHF affects ∼5.8 million Americans.
- Estimated 2012 cost of CHF is $40 billion
- ADHF is the leading Medicare diagnosis for hospitalized patients ≥65 yr old.
ETIOLOGY
Underlying causes and acute precipitants
- Decreased myocardial contractility:
- Myocardial ischemia/infarction
- Cardiomyopathy (including, alcoholic and pregnancy-related)
- Myocarditis
- Dysrhythmias
- Decreased contractile efficiency:
- Drug related (negative inotropes)
- Metabolic disorders
- Pressure overload states:
- HTN
- Valvular abnormalities
- Arrhythmia
- Congenital heart disease
- Pulmonary embolism
- Primary pulmonary hypertension, sleep apnea syndromes (right heart failure)
- Restricted cardiac output:
- Myocardial infiltrative disease
- Volume overload:
- Dietary indiscretion (sodium overload)
- Drugs leading to sodium retention (glucocorticoids, NSAIDs)
- Overload due to transfusion or IV fluid
- High demand states:
- Hyperthyroidism, thyrotoxicosis
- Pregnancy
- A-V fistula
- Beriberi (thiamine deficiency)
- Paget disease
- Severe anemia
- Aortic insufficiency
- Pediatric etiologies: Volume/pressure overload lesions vs. acquired HD:
- 1st 6 mo: VSD and PDA
- Older children: Subvalvular aortic stenosis, coarctation
- Acquired dysfunction: Nonspecific age of onset, including myocarditis, valvular disease, and cardiomyopathies; cocaine/stimulant abuse in adolescents
DIAGNOSIS
SIGNS AND SYMPTOMS
- Poor perfusion:
- Fatigue, somnolence, lightheadedness
- Palpitations, or irregular pulse
- Shortness of breath
- Cool extremities
- Worsening renal function
- Congestion
- Dyspnea, cough
- Orthopnea
- Paroxysmal nocturnal dyspnea
- Evidence of sleep disordered breathing
- Decreased exercise tolerance
- Elevated JVD or abdominojugular reflex
- Dependent edema (poor sensitivity and specifity)
- Rales and/or wheezing, (absent in 80% with chronically elevated filling pressure due to compensatory lymphatic drainage)
- Pleural effusion, dullness at lung bases
- S3 gallop and/or S4.
- Laterally displaced apical impulse
- Hepatic enlargement/tenderness
- Nausea
- Ascites
- ADHF with hemodynamic instability:
- Confusion, anxiety, syncope
- Tachypnea
- Tachycardia
- Hypotension
- Cool, pale or cyanotic extremities
- Narrow pulse pressure or pulsus alternans
- Cheyne–Stokes respirations
ESSENTIAL WORKUP
- The CXR is important in confirming the diagnosis and assessing severity.
- 12-hr radiographic lag from onset of symptoms may occur.
- Radiographic findings may persist for several days despite clinical improvement.
DIAGNOSIS TESTS & NTERPRETATION
Lab
- Chemistry/electrolytes:
- Establish baseline renal function when initiating diuretics, or ACE inhibitors
- Hyperkalemia possible with low output
- Hyponatremia associated with poor prognosis
- CBC:
- Anemia can cause or exacerbate failure
- Infection can cause or exacerbate failure
- Liver function tests:
- Increase suggests hepatic congestion, or ischemia.
- Thyroid function tests:
- Specifically in patients >65 yr old or in a-fib
- Cardiac enzymes:
- Evaluate for ischemia or infarction
- ANA and rheumatoid factor: Suspected lupus
- Viral panel: Suspected myocarditis
- BNP:
- Useful for distinguishing cardiac vs. pulmonary cause of dyspnea
- BNP >500 pg/mL, HF likely (ppv 90%)
- BNP <100 pg/mL, HF unlikely, (npv 90%)
- BNP 100–500 pg/mL, consider PE, cor pulmonale, renal failure, or stable underlying HF.
- REDHOT II Study: BNP levels are better than physicians at predicting which patients are more likely to have bad outcomes
- EPs were blinded to BNP values. 78% of patients discharged from ED had BNP >400.
- Of those discharged with a BNP >400, 90-day mortality was 9%
- BNP levels rise with age and are affected by gender, comorbidity, and drug therapy and should not be used in isolation
- BNP levels may be low in acute pulmonary edema (<1–2 hr) and obesity (BMI >30).
- NT-proBNP: Cleavage product of prohormone.
- NT-proBNP >1,000 pg/mL predictive of HF
- NT-proBNP <300 pg/mL unlikely to be HF
Imaging
- CXR:
- Cardiomegaly (sensitive)
- Specific signs of CHF:
- Cephalization (vascular prominence in the upper lungs due to fluid overload)
- Interstitial edema/Kerley B lines
- Alveolar edema
- Effusions (usually right sided)
- Bilateral confluent perihilar infiltrates leading to classic butterfly pattern:
- May be asymmetric and mistaken for pneumonia
- EKG:
- Underlying cardiac ischemia
- Presence of dysrhythmias
- Left-ventricular hypertrophy
- Heart block
- Normal EKG has high negative predictive value for systolic dysfunction.
- 2-D Cardiac Echo:
- Ejection fraction
- Acute valvular pathology
- Pericardial tamponade
- Pericardial thickening in constrictive pericarditis
- Ventricle dilation, or hypertrophy
- Regional wall motion abnormalities